“This new finding sheds light on how the mutation causes these disorders, and it provides us with a marker that helps us track disease progression in patients with this disorder and potentially combat the disease,” says senior author Leonard Petrucelli, Ph.D., a molecular neuroscientist and director of the Department of Neuroscience at Mayo Clinic in Florida.
Jean-Martin Charcot, born November 29, 1825 was a French neurologist and professor of anatomical pathology. He is known as “the founder of modern neurology” and is “associated with at least 15 medical eponyms“, including Charcot-Marie-Tooth disease and amyotrophic lateral sclerosis (motor neuron disease). One of Charcot’s greatest legacies as a clinician is his contribution to [...]
$2.1M Awarded to Scripps Scientists to Study Several Compounds with Potential to Improve QOL for ALS Patients
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.
The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into collaboration with Neurotune to investigate a potential treatment for ALS (aka Motor Neuron or Lou Gehrig’s disease).
“Using patient stem cells to model MND in a dish offers untold possibilities for how we study the cause of this terrible disease as well as accelerating drug discovery by providing a cost effective way to test many thousands of potential treatments.”